Cari­bou to slash pre­clin­i­cal al­lo­gene­ic CAR-NK work, lay off 12% of staff

Cari­bou Bio­sciences is cut­ting its CAR-NK re­search and lay­ing off 21 em­ploy­ees, or 12% of its staff, the com­pa­ny an­nounced Tues­day.

“We are un­der­tak­ing this …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER